Papagudi G. Subramanian

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Journal: JCO global oncology

Published: September 03, 2026

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.

Journal: Cytometry. Part B, Clinical cytometry

Published: April 12, 2026

Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Journal: JCO global oncology

Published: February 20, 2026

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Journal: Cytometry. Part B, Clinical cytometry

Published: February 01, 2026

TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia.

TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia.

Journal: Molecular carcinogenesis

Published: January 15, 2026

Higher levels of eosinophilia in erythroderma and sub-erythroderma correlate with a diagnosis of atopic dermatitis.

Higher levels of eosinophilia in erythroderma and sub-erythroderma correlate with a diagnosis of atopic dermatitis.

Journal: Journal of the American Academy of Dermatology

Published: January 07, 2026

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 10, 2025

Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?

Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?

Journal: Journal of clinical pathology

Published: October 01, 2025

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 27, 2025

Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.

Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.

Journal: Blood cancer journal

Published: July 22, 2025

Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.

Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.

Journal: Blood cancer journal

Published: June 28, 2025

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Journal: Blood cancer journal

Published: May 20, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026